ArticleCancers2025

Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study.

Maen Abdelrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.